Header Logo

Connection

Haley Melikian to Dopamine

This is a "connection" page, showing publications Haley Melikian has written about Dopamine.
Connection Strength

1.930
  1. Bolden NC, Pavchinskiy RG, Melikian HE. Dopamine transporter endocytic trafficking: Neuronal mechanisms and potential impact on DA-dependent behaviors. J Neurochem. 2025 Jan; 169(1):e16284.
    View in: PubMed
    Score: 0.894
  2. Fagan RR, Kearney PJ, Melikian HE. In Situ Regulated Dopamine Transporter Trafficking: There's No Place Like Home. Neurochem Res. 2020 Jun; 45(6):1335-1343.
    View in: PubMed
    Score: 0.640
  3. Fagan RR, Kearney PJ, Luethi D, Bolden NC, Sitte HH, Emery P, Melikian HE. Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster. Mol Psychiatry. 2021 12; 26(12):7793-7802.
    View in: PubMed
    Score: 0.177
  4. Navaroli DM, Melikian HE. Insertion of tetracysteine motifs into dopamine transporter extracellular domains. PLoS One. 2010 Feb 09; 5(2):e9113.
    View in: PubMed
    Score: 0.080
  5. Boudanova E, Navaroli DM, Stevens Z, Melikian HE. Dopamine transporter endocytic determinants: carboxy terminal residues critical for basal and PKC-stimulated internalization. Mol Cell Neurosci. 2008 Oct; 39(2):211-7.
    View in: PubMed
    Score: 0.071
  6. Boudanova E, Navaroli DM, Melikian HE. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent. Neuropharmacology. 2008 Mar; 54(3):605-12.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.